122 related articles for article (PubMed ID: 37916357)
1. Are nonfunctioning adrenal incidentalomas really nonfunctioning? A retrospective single-center study.
Güneş E; Güneş M
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9895-9901. PubMed ID: 37916357
[TBL] [Abstract][Full Text] [Related]
2. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
3. The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.
Arruda M; Mello Ribeiro Cavalari E; Pessoa de Paula M; Fernandes Cordeiro de Morais F; Furtado Bilro G; Alves Coelho MC; de Oliveira E Silva de Morais NA; Choeri D; Moraes A; Vieira Neto L
J Hum Hypertens; 2017 Dec; 32(1):3-11. PubMed ID: 29176595
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
5. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
Favero V; Aresta C; Parazzoli C; Cairoli E; Eller-Vainicher C; Palmieri S; Salcuni AS; Arosio M; Persani L; Scillitani A; Morelli V; Chiodini I
Cardiovasc Diabetol; 2023 May; 22(1):102. PubMed ID: 37131218
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
[TBL] [Abstract][Full Text] [Related]
8. Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.
Kim JH; Kim MJ; Lee JH; Yoon JW; Shin CS
Endocr Pract; 2020 Dec; 26(12):1406-1415. PubMed ID: 33471732
[TBL] [Abstract][Full Text] [Related]
9. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Dexamethasone Suppression Test Cortisol Level > 0.9 μg/dL and Depression and Quality of Life in Adrenal Incidentalomas: Single Centre Observational Case-Control Study Depression and Quality of Life in Adrenal Incidentalomas.
Güneş M; Güneş E; Kaya Mİ; Küçükelyas HD; Barut H; Öner S
Endocr Pract; 2024 May; ():. PubMed ID: 38729569
[TBL] [Abstract][Full Text] [Related]
11. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
Morelli V; Palmieri S; Lania A; Tresoldi A; Corbetta S; Cairoli E; Eller-Vainicher C; Arosio M; Copetti M; Grossi E; Chiodini I
Eur J Endocrinol; 2017 Jul; 177(1):73-83. PubMed ID: 28468767
[TBL] [Abstract][Full Text] [Related]
13. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
14. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
[TBL] [Abstract][Full Text] [Related]
15. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
Rodrigues MO; Moraes AB; de Paula MP; Pereira VA; Leão ATT; Vieira Neto L
J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan.
Aoe M; Okada A; Usui T; Manaka K; Nangaku M; Makita N
Endocr J; 2020 Jun; 67(6):645-654. PubMed ID: 32213723
[TBL] [Abstract][Full Text] [Related]
17. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.
Morelli V; Eller-Vainicher C; Palmieri S; Cairoli E; Salcuni AS; Scillitani A; Carnevale V; Corbetta S; Arosio M; Della Casa S; Muscogiuri G; Spada A; Chiodini I
J Clin Endocrinol Metab; 2016 Jul; 101(7):2768-75. PubMed ID: 27144939
[TBL] [Abstract][Full Text] [Related]
19. Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Ohno Y; Sone M; Inagaki N; Takeda Y; Kurihara I; Tsuiki M; Ichijo T; Wada N; Katabami T; Ogawa Y; Okamura S; Fukuoka T; Kai T; Izawa S; Yoshikawa Y; Hashimoto S; Yamada M; Chiba Y; Naruse M;
J Clin Endocrinol Metab; 2019 Oct; 104(10):4382-4389. PubMed ID: 31058960
[TBL] [Abstract][Full Text] [Related]
20. Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance.
Arduc A; Isik S; Ozuguz U; Tutuncu YA; Kucukler FK; Ozcan HN; Berker D; Guler S
Endocr Res; 2014; 39(3):99-104. PubMed ID: 24152247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
